about
Hyperglycemic crises in adult patients with diabetesInsulin delivery methods: Past, present and futureCompact and Thermosensitive Nature-inspired Micropump.The evidence base for diabetes technology: appropriate and inappropriate meta-analysisClosed-loop glucose control: psychological and behavioral considerationsEffects of pulsatile subcutaneous injections of insulin lispro on plasma insulin concentration levels.Continuous subcutaneous insulin infusion in adult type 1 diabetes mellitus: data from a registry at the University Medical Centre Ljubljana, Slovenia.In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.Evolving trends in insulin delivery in pursuit of improvements in diabetes management.Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes.Novel methodology to determine the accuracy of the OmniPod insulin pump: a key component of the artificial pancreas system.Analysis of novel methods to determine the accuracy of the OmniPod insulin pump: a key component of the artificial pancreas system.Parental involvement buffers associations between pump duration and metabolic control among adolescents with type 1 diabetesMulticenter user evaluation of ACCU-CHEKĀ® Combo, an integrated system for continuous subcutaneous insulin infusion.Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.Psychosocial assessment of artificial pancreas (AP): commentary and review of existing measures and their applicability in AP researchInitiating insulin therapy in children and adolescents with type 1 diabetes mellitusUse of sensors in the treatment and follow-up of patients with diabetes mellitus.Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.Cross-sectional survey and retrospective analysis of a large cohort of adults with type 1 diabetes with long-term continuous subcutaneous insulin infusion treatmentInsulin pump use and glycemic control in adolescents with type 1 diabetes: Predictors of change in method of insulin delivery across two yearsInsulin pumps: what every school nurse needs to know.Insulin Pump Therapy Is Associated with Lower Rates of Retinopathy and Peripheral Nerve AbnormalityA Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.Type 1 diabetes complicated with uncontrollable adult cyclic vomiting syndrome: a case reportType 1 Diabetes Patients Using Continuous Subcutaneous Insulin Infusion Therapy: Feeling Burdened Correlated with Factors.Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.Safety and side effects of the insulin analogues.Quality of life and technology: impact on children and families with diabetesReduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies.Intensive insulin therapy in pregnancy: strategies for successful implementation in pregestational diabetes mellitus.Diabetes: advances in treatment.A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes.Past, present, and future of insulin pump therapy: better shot at diabetes control.Impact of insulin pump on quality of life of diabetic patients.Glucose variability assessed by low blood glucose index is predictive of hypoglycemic events in patients with type 1 diabetes switched to pump therapy.Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy.
P2860
Q22241293-5D7C6772-375D-4019-BBFE-2583352E2F48Q26750895-7BA4A140-4CFF-4BA9-9D57-E246B07C4266Q30370686-85944B63-2DC7-4584-99D6-1E64A36239D4Q30409804-72FDEC18-C277-44EA-B8D2-1F696A67922BQ30424290-309D05A6-2CEE-4E4D-B975-67FCC5B2303BQ30439244-2A9F6403-075F-4BAB-9FDD-246739B88B38Q30564482-36323F06-AA2B-438A-BDC0-FB1E1C75F0C9Q33321671-07563908-584B-4095-BE25-080319C8B96BQ33879565-02BB45D7-08C0-4935-B40E-C8FC166709CCQ33932057-3F6C3822-1DFE-44AA-84FC-FF9BE86CF046Q34018165-61DA825B-86A5-4112-ACB6-21445CFB6D30Q34119580-5C463D33-3186-4FE6-85E8-46E9508C795FQ34120990-AA82312B-039A-4B13-87CF-63B235956059Q34120994-F7490F55-8418-4137-BFEB-C08258B75067Q34204140-0C9D8C41-6597-4442-B38F-D517B38533A7Q34419993-CA42A471-791F-4562-AD74-BCF29730894FQ34449270-855ABA98-A12F-499A-B8EF-32200448513EQ35193787-7C662A22-4DBF-4CAF-8719-62CE6553E7C2Q35549532-A383E869-FBF4-4AA1-8315-8FD0E4B07844Q35594010-B9EBD71C-8627-47D4-86D6-84055DFA9212Q35627208-349AB506-B194-4C56-9B05-B60FCD216DE1Q35682636-0CE4B8B9-5F48-4046-B9D3-CAF892DAB8B8Q35690538-D8B47FC9-44CB-432C-B02D-0F5F9925D449Q35709886-783504CF-1821-4C69-B7F3-11CB698DC67BQ35981134-9828FD38-F338-4A57-910E-09FC61067062Q36076863-11754A80-3DCE-4629-9CF3-ED9F2B7335CCQ36086655-CE276C4D-2FAF-4427-B80E-4AF7485F3AC1Q36225598-83D402AF-ABC4-40E5-AC7D-DFC7C30CBE83Q36297813-7BF6A750-FE51-4A61-A1E8-44AA90452A14Q36340429-C66A71D0-6BE5-4BA1-A395-7D5BBD8A8235Q36349754-3A34D176-D17B-4E6D-AE36-1CD27CBF4E21Q36464623-627F916A-3560-4857-A1CE-B1996E64D8A8Q36683272-CA81FEB8-0D67-4DA4-97C8-DBF7A52DC28BQ36793050-ADEDACAE-0AC5-4593-99A7-7E66F6201F7AQ36834433-1A9A7AEC-6E06-4DF5-BD9D-0A4908387E02Q36838643-5EF5C19F-DD44-42EB-8320-226A39E8155DQ36924597-861E4322-7A5F-4C1C-99CD-8A9B6BA97A3EQ37015613-7FC1D7DD-605C-4189-ACEA-BC077ECE4339Q37022673-84578648-755B-4877-B7B4-10F70C535865Q37207691-DCD93FCE-9D03-432A-83C6-7E0FB77EF918
P2860
description
2003 nĆ® lÅ«n-bĆ»n
@nan
2003 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Ō±ÕŗÖÕ«Õ¬Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2003 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ”ÕŗÖÕ«Õ¬Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2003幓ć®č«ę
@ja
2003幓č«ę
@yue
2003幓č«ę
@zh-hant
2003幓č«ę
@zh-hk
2003幓č«ę
@zh-mo
2003幓č«ę
@zh-tw
2003幓č®ŗę
@wuu
name
Insulin pump therapy: a meta-analysis.
@ast
Insulin pump therapy: a meta-analysis.
@en
type
label
Insulin pump therapy: a meta-analysis.
@ast
Insulin pump therapy: a meta-analysis.
@en
prefLabel
Insulin pump therapy: a meta-analysis.
@ast
Insulin pump therapy: a meta-analysis.
@en
P1433
P1476
Insulin pump therapy: a meta-analysis.
@en
P2093
Jeanne Antisdel-Lomaglio
Roopa Seshadri
P304
P356
10.2337/DIACARE.26.4.1079
P407
P577
2003-04-01T00:00:00Z